X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1199) 1199
Newspaper Article (307) 307
Publication (127) 127
Paper (108) 108
Patent (66) 66
Conference Proceeding (43) 43
Report (26) 26
Book / eBook (20) 20
Book Chapter (17) 17
Book Review (10) 10
Dissertation (7) 7
Magazine Article (7) 7
Newsletter (3) 3
Data Set (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (254) 254
humans (215) 215
female (158) 158
physics (144) 144
experiment (121) 121
cern lhc coll (117) 117
experimental results (117) 117
high energy physics - experiment (110) 110
male (108) 108
particle physics (108) 108
13000 gev-cms (102) 102
hep (102) 102
physics - high energy physics - experiment (101) 101
analysis (93) 93
high energy physics (91) 91
oncology (91) 91
p p: scattering (89) 89
middle aged (86) 86
p p: colliding beams (84) 84
adult (76) 76
animals (73) 73
phenomenology (66) 66
aged (64) 64
breast cancer (63) 63
ex (62) 62
surgery (61) 61
research (55) 55
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (50) 50
cancer (49) 49
care and treatment (48) 48
health aspects (48) 48
breast neoplasms - drug therapy (47) 47
materials science, multidisciplinary (43) 43
cms (42) 42
chemotherapy (40) 40
physics of elementary particles and fields (40) 40
otorhinolaryngology (39) 39
medicine & public health (38) 38
treatment outcome (38) 38
medicine (37) 37
background (36) 36
india (36) 36
risk factors (36) 36
hadron-hadron scattering (34) 34
aged, 80 and over (33) 33
breast neoplasms - pathology (32) 32
elections (31) 31
nuclear experiment (31) 31
leadership (30) 30
physics, applied (29) 29
studies (29) 29
mass dependence (28) 28
scattering [p p] (28) 28
colliding beams [p p] (27) 27
patients (27) 27
usage (27) 27
calculating (26) 26
computing (26) 26
counting (26) 26
physics, condensed matter (26) 26
young adult (26) 26
cern lab (25) 25
electric digital data processing (25) 25
mice (25) 25
original (25) 25
channel cross section: upper limit (24) 24
crystals (24) 24
microbiology (24) 24
survival (24) 24
chemistry (23) 23
drug therapy (23) 23
presidents (23) 23
abridged index medicus (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
channel cross section: branching ratio: upper limit (22) 22
nanoparticles (22) 22
114 physical sciences (21) 21
diseases of the circulatory system (21) 21
metastasis (21) 21
original article (21) 21
therapy (21) 21
x-ray diffraction (21) 21
adolescent (20) 20
article (20) 20
characterization and evaluation of materials (20) 20
growth (20) 20
higgs particle: hadroproduction (20) 20
proteins (20) 20
quality of life (20) 20
retrospective studies (20) 20
trastuzumab (20) 20
diagnosis (19) 19
hygiene (19) 19
medicine, research & experimental (19) 19
research article (19) 19
transverse momentum: missing-energy (19) 19
chemistry, multidisciplinary (18) 18
clinical trials (18) 18
human necessities (18) 18
material science (18) 18
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
UTL at Downsview - May be requested (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Robarts - Storage (1) 1
Robarts - Withdrawn (1) 1
Royal Ontario Museum - Far Eastern (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Medicine, ISSN 1741-7015, 08/2014, Volume 12, Issue 1, pp. 129 - 129
Journal Article
The Oncologist, ISSN 1083-7159, 06/2017, Volume 22, Issue 6, pp. 754 - 755
This letter describes preliminary results of a follow‐up study that was performed to assess the safety profile of palbociclib in premenopausal women with... 
Journal Article
Oncologist, ISSN 1083-7159, 06/2017, Volume 22, Issue 6, p. 755
Journal Article
The Oncologist, ISSN 1083-7159, 6/2017, Volume 22, Issue 6, pp. 754 - 755
This letter describes preliminary results of a follow‐up study that was performed to assess the safety profile of palbociclib in premenopausal women with... 
Letters to the Editor
Journal Article
The Oncologist, ISSN 1083-7159, 06/2017, Volume 22, Issue 6, pp. 754 - 755
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
Psychological Studies, ISSN 0033-2968, 08/2019
Journal Article
EUROPE-REVUE LITTERAIRE MENSUELLE, ISSN 0014-2751, 04/2001, Volume 79, Issue 864, pp. 24 - 35
Journal Article
Annals of pediatric cardiology, ISSN 0974-2069, 05/2019, Volume 12, Issue 2, pp. 176 - 177
The usual sources of pulmonary blood flow in pulmonary atresia (PA) with(VSD) are patent ductus arteriosus and aortopulmonary collaterals. However, rarely... 
Vascular fistula | Congenital heart disease | Fistula | Intubation | Pulmonary arteries | Coronary vessels | Veins & arteries | Collateral circulation | ventricular septal defect with pulmonary atresia | coronary-pulmonary artery fistula | Images
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 732 - 742
Summary Background The antibody–drug conjugate trastuzumab emtansine is indicated for the treatment of patients with HER2-positive metastatic breast cancer... 
Hematology, Oncology and Palliative Medicine | RECEPTOR | ONCOLOGY | PERTUZUMAB | DOCETAXEL | GUIDELINES | Capecitabine - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Response Evaluation Criteria in Solid Tumors | Antineoplastic Agents - therapeutic use | Hand-Foot Syndrome - etiology | Diarrhea - chemically induced | Young Adult | Breast Neoplasms - chemistry | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Lapatinib | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Trastuzumab - administration & dosage | Breast Neoplasms, Male - drug therapy | Maytansine - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms, Male - chemistry | Disease-Free Survival | Retreatment | Taxoids - administration & dosage | Vomiting - chemically induced | Aspartate Aminotransferases - blood | Capecitabine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Quinazolines - adverse effects | Aged | Breast Neoplasms, Male - pathology | Receptor, ErbB-2 - analysis | Bridged-Ring Compounds - administration & dosage | Care and treatment | Breast cancer | Metastasis | Patient outcomes | Analysis
Journal Article
Journal Article
Journal of Human Values, ISSN 0971-6858, 5/2018, Volume 24, Issue 2, pp. 73 - 82
The study explored the role of moral identity (internalization and symbolization) in the civic engagement (attitude and behaviour) of youth through ethical... 
civic engagement | Moral identity | ethical ideology | religiosity
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 209 - 219
In women with hormone-receptor–positive metastatic breast cancer that had progressed after endocrine therapy, palbociclib plus fulvestrant was associated with... 
TARGET | MEDICINE, GENERAL & INTERNAL | THERAPY | FULVESTRANT | CLINICAL-TRIALS | CYCLIN D | RESISTANCE | MUTATIONS | COMBINATION | ESTROGEN-RECEPTOR | 4/6 INHIBITOR PALBOCICLIB | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Estradiol - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Protein Kinase Inhibitors - adverse effects | Receptors, Progesterone - analysis | Pyridines - adverse effects | Aged, 80 and over | Estradiol - adverse effects | Adult | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyridines - therapeutic use | Double-Blind Method | Estradiol - therapeutic use | Biomarkers - analysis | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aged | Receptor, ErbB-2 - analysis | Women | Hormone receptors | Care and treatment | Usage | Breast cancer | Diagnosis | Health aspects | Thrombocytopenia | Leukopenia | Endocrine therapy | Fatigue | Metastasis | Cancer therapies | Cyclin-dependent kinase 4 | Fulvestrant | Metastases | Epidermal growth factor | Womens health | S phase | Cell cycle | Neutropenia | G1 phase
Journal Article
The oncologist, 06/2017, Volume 22, Issue 6, p. 754
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 19, pp. 1783 - 1791
Women with metastatic breast cancer that had progressed during treatment with trastuzumab plus a taxane were assigned to lapatinib plus capecitabine or to... 
CAPECITABINE | LAPATINIB | MEDICINE, GENERAL & INTERNAL | THERAPY | PHASE-II | ANTIBODY | RECEPTOR | PLUS | Capecitabine | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Young Adult | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Fluorouracil - analogs & derivatives | Maytansine - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Survival Rate | Maytansine - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | Breast Neoplasms - mortality | Aged | Receptor, ErbB-2 - analysis | Deoxycytidine - analogs & derivatives | Trastuzumab | Drugs | Dose-response relationship (Biochemistry) | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Comparative analysis | Thrombocytopenia | Chemotherapy | Epidermal growth factor | Vomiting | Diarrhea | Cytotoxicity | Nausea | Survival | ErbB-2 protein | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article